C
Chememan PCL
SET:CMAN
Chememan PCL
SET:CMAN
Price:
2.62
THB
Market Closed
Market Cap:
฿2.5B
Balance Sheet
Balance Sheet Decomposition
Chememan PCL
Chememan PCL
Balance Sheet Decomposition is not available for
Chememan PCL
Chememan PCL
Balance Sheet
Chememan PCL
Chememan PCL
Currency: THB
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
17
|
36
|
43
|
46
|
126
|
215
|
494
|
194
|
123
|
0
|
0
|
|
| Cash |
17
|
36
|
43
|
46
|
126
|
215
|
494
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
194
|
123
|
0
|
0
|
|
| Total Receivables |
306
|
247
|
339
|
383
|
411
|
512
|
352
|
477
|
558
|
486
|
612
|
|
| Accounts Receivables |
282
|
203
|
287
|
336
|
358
|
438
|
298
|
477
|
553
|
0
|
0
|
|
| Other Receivables |
24
|
44
|
52
|
48
|
53
|
74
|
54
|
0
|
5
|
0
|
0
|
|
| Inventory |
246
|
249
|
254
|
280
|
312
|
389
|
367
|
515
|
424
|
369
|
391
|
|
| Other Current Assets |
35
|
17
|
14
|
30
|
25
|
32
|
39
|
144
|
139
|
101
|
77
|
|
| Total Current Assets |
603
|
549
|
650
|
739
|
875
|
1 149
|
1 252
|
1 331
|
1 244
|
1 121
|
1 495
|
|
| PP&E Net |
1 374
|
1 578
|
2 037
|
2 370
|
2 747
|
3 830
|
4 076
|
4 702
|
4 584
|
4 382
|
4 150
|
|
| PP&E Gross |
1 374
|
1 578
|
2 037
|
2 370
|
2 747
|
3 830
|
4 076
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
756
|
850
|
973
|
1 125
|
1 497
|
1 686
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
8
|
8
|
8
|
5
|
391
|
381
|
378
|
372
|
368
|
371
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
62
|
62
|
62
|
62
|
62
|
62
|
|
| Note Receivable |
0
|
54
|
57
|
50
|
45
|
40
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
14
|
108
|
196
|
211
|
301
|
286
|
338
|
308
|
|
| Other Long-Term Assets |
36
|
33
|
30
|
35
|
45
|
132
|
122
|
249
|
220
|
7
|
6
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
62
|
62
|
62
|
62
|
62
|
62
|
|
| Total Assets |
2 013
N/A
|
2 223
+10%
|
2 782
+25%
|
3 217
+16%
|
3 824
+19%
|
5 800
+52%
|
6 103
+5%
|
7 022
+15%
|
6 768
-4%
|
6 395
-6%
|
6 472
+1%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
206
|
105
|
150
|
143
|
139
|
182
|
134
|
513
|
458
|
0
|
0
|
|
| Accrued Liabilities |
67
|
45
|
60
|
61
|
70
|
69
|
34
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
365
|
393
|
394
|
264
|
155
|
648
|
1 098
|
1 067
|
947
|
1 049
|
933
|
|
| Current Portion of Long-Term Debt |
135
|
147
|
215
|
96
|
102
|
448
|
646
|
496
|
613
|
589
|
510
|
|
| Other Current Liabilities |
20
|
120
|
136
|
159
|
153
|
403
|
205
|
78
|
38
|
32
|
50
|
|
| Total Current Liabilities |
793
|
810
|
956
|
724
|
618
|
1 750
|
2 116
|
2 154
|
2 057
|
2 039
|
1 959
|
|
| Long-Term Debt |
350
|
442
|
689
|
1 196
|
905
|
1 533
|
1 658
|
2 425
|
2 209
|
1 778
|
1 814
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
0
|
74
|
71
|
70
|
69
|
70
|
67
|
|
| Minority Interest |
0
|
7
|
6
|
5
|
4
|
119
|
102
|
103
|
78
|
54
|
39
|
|
| Other Liabilities |
36
|
53
|
67
|
74
|
77
|
198
|
161
|
80
|
82
|
88
|
85
|
|
| Total Liabilities |
1 179
N/A
|
1 312
+11%
|
1 718
+31%
|
1 999
+16%
|
1 605
-20%
|
3 674
+129%
|
4 109
+12%
|
4 832
+18%
|
4 493
-7%
|
4 028
-10%
|
3 964
-2%
|
|
| Equity | ||||||||||||
| Common Stock |
450
|
650
|
650
|
720
|
960
|
960
|
960
|
960
|
960
|
960
|
960
|
|
| Retained Earnings |
386
|
262
|
416
|
426
|
540
|
473
|
334
|
433
|
585
|
682
|
867
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
77
|
737
|
737
|
737
|
737
|
737
|
737
|
737
|
|
| Other Equity |
2
|
2
|
2
|
5
|
18
|
44
|
37
|
60
|
7
|
13
|
55
|
|
| Total Equity |
834
N/A
|
911
+9%
|
1 064
+17%
|
1 217
+14%
|
2 219
+82%
|
2 126
-4%
|
1 995
-6%
|
2 190
+10%
|
2 275
+4%
|
2 366
+4%
|
2 508
+6%
|
|
| Total Liabilities & Equity |
2 013
N/A
|
2 223
+10%
|
2 782
+25%
|
3 217
+16%
|
3 824
+19%
|
5 800
+52%
|
6 103
+5%
|
7 022
+15%
|
6 768
-4%
|
6 395
-6%
|
6 472
+1%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
450
|
650
|
650
|
720
|
960
|
960
|
960
|
960
|
960
|
960
|
960
|
|
Switch to:
Switch to:
See Also
Discover More
